南風化工(000737.SZ)第三季度預虧755萬-815萬元 同比盈轉虧
格隆匯10月11日丨南風化工(000737.SZ)公佈,預計2021年前三季度歸屬於上市公司股東的淨利潤170萬元-230萬元,同比下降97.69%-98.29%;其中,第三季度歸屬於上市公司股東的淨虧損755萬元-815萬元,上年同期盈利560.64萬元。
本期業績同比變動原因:一是上年同期公司完成了元明粉分公司資產及負債出售,形成較大的資產處置收益;二是公司面對複雜的國內外環境,採取優化銷售策略、持續技術創新和技術改造等多種措施,提高了公司的盈利能力。
本季度業績變動原因:一是主要產品受海運費大幅上漲、下游需求不足影響,銷量下滑、價格下降;二是主要原輔材料價格上漲,產品生產成本升高。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.